Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2007

View Archived Issues

Recent Merck and AstraZeneca patents report new therapeutic agents for metabolic disorders

Recent patents cover therapeutic agents for inflammatory disorders

Two phase I studies of PTC-124 in healthy adults completed

FdCyd and THU studied for treatment of solid tumors

Novel camptothecin conjugate with promising efficacy and pharmacokinetic profile

Replacement of regular insulin with Oral-lyn studied in adults, adolescents

Certolizumab pegol inhibits cytokine production by monocytes

Preclinical profile of MORAb-009 reported by Morphotek

Vaccine targeting prostatic acid phosphatase tested in prostate cancer patients

Promising preclinical profile of STI-1698, a topoisomerase I inhibitor developed at Sigma-Tau

LX-1031 begins phase Ib study for IBS

Introgen initiates efficacy analyses of Advexin phase III study

NS-2359 begins second phase II study for depression

U.S. development of CollaRx Gentamicin Surgical Implant to open at phase III

Agensys discover AGS-16 as a novel target for the treatment of kidney cancer

Exelixis cleared to resume clinical testing of XL-999

Dosing completed in phase I metastatic melanoma study of Provecta

Novartis in-licenses CYT002-NicQb for treatment of nicotine addiction

New data confirm oral bioavailability of AL-309

PCK-3145 shows evidence of clinical activity in metastatic prostate cancer patients

Miraxion fails to meet endpoints in phase III Huntington's studies

Phase IIa results for i.v. cannabinor in postoperative pain

EpiCeram comparable to Cutivate in treating atopic dermatitis symptoms

Alitretinoin shows retreatment benefit in chronic hand eczema

Abbott discontinues development of levosimendan in U.S.

Singulair approved to prevent exercise-induced bronchoconstriction

Novel therapeutic agents for atherosclerosis reported in recent Merck and Merck Frosst patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...